Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory.

Journal of virological methods - 1 Jul 2004

Maes Bart, Schrooten Yoeri, Snoeck Joke, Derdelinckx Inge, Van Ranst Marc, Vandamme Anne-Mieke, Van Laethem Kristel

Abstract excerpt

Since there are indications of an increasing amount of non-B subtypes in Western Europe it was decided to assess the performance of the ViroSeq HIV-1 Genotyping System on a set of samples from the AIDS Reference Laboratory at the University Hospitals Leuven, a hospital with an increasing number of patients infected with non-B subtypes. The set consisted of 383 samples comprising 12 different subtypes and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Belgium
Share to Genetic Techniques

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to HIV Infections

Share to Nucleic Acid Amplification Techniques

Share to Virology

Source

Identifiers

PMID: 15109820
DOI: 10.1016/j.jviromet.2004.02.005

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Performance of ViroSeq HIV-1 Genotyping System in routine practice at a Belgian clinical laboratory.PMID 15109820Read ↗

Evaluation of two commercial kits for the detection of genotypic drug resistance on a panel of HIV type 1 subtypes A through J.Semantic proximity Read ↗

Genetic diversity of env V3 loop sequences in HIV type 1-infected homosexuals, heterosexuals, intravenous drug users, and hemophilia patients in norway: high prevalence of subtype B and detection of subtype C.Semantic proximity Read ↗

Performance of the ViroSeq HIV-1 genotyping system v2.0 on HIV-1 strains circulating in Senegal.Semantic proximity Read ↗

Analysis of HIV-1 variants by cloning DNA generated with the ViroSeq HIV-1 Genotyping System.Semantic proximity Read ↗

Development of the 1st International Reference Panel for HIV-1 RNA genotypes for use in nucleic acid-based techniques.Semantic proximity Read ↗

Performance evaluation of an in-house human immunodeficiency virus type-1 protease-reverse transcriptase genotyping assay in Cameroon.Semantic proximity Read ↗

Performance evaluation of the two protease sequencing primers of the Trugene HIV-1 genotyping kit.Semantic proximity Read ↗

Comparison of four commercial viral load techniques in an area of non-B HIV-1 subtypes circulation.Semantic proximity Read ↗

Modifications and substitutions of the RNA extraction module in the ViroSeq HIV-1 genotyping system version 2: effects on sensitivity and complexity of the assay.Semantic proximity Read ↗

Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.Semantic proximity Read ↗

Performance of the automated Abbott RealTime™ HIV-1 assay on a genetically diverse panel of specimens from BrazilSemantic proximity Read ↗

Description of two commercially available assays for genotyping of HIV-1.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.